Stock listing
ASX:NXN Nexsen Limited Share Price
Follow Nexsen Limited into a list and get an email when it puts out news.
Share price · ASX:NXN
$0.135 AUD +0.005 (+3.8%)
Close on Nov 19, 2026
- Day range
- $0.130 – $0.135 AUDNov 19, 2026
- Volume
- 236,916 sharesNov 19, 2026
- Market cap
- $27.27M AUDAt the close on Nov 19, 2026 · price × 202.0M shares outstanding
- 52-week range
- $0.105 – $0.345 AUDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
- Traded on an average day
- $23,476 AUDMedian day 68,939 shares · 7 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026

Daily closes
Last 3 months, Aug 19, 2026 – Nov 19, 2026 · ASX:NXN · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.135 | +0.005 | +3.8% | $0.130 | $0.135 | $0.130 | 236,916 | |
| $0.130 | -0.005 | -3.7% | $0.130 | $0.130 | $0.130 | 5,810 | |
| $0.135 | -0.015 | -10.0% | $0.135 | $0.135 | $0.130 | 204,461 | |
| $0.150 | -0.005 | -3.2% | $0.155 | $0.155 | $0.150 | 10,833 | |
| $0.155 | +0.005 | +3.3% | $0.152 | $0.155 | $0.152 | 10,000 | |
| $0.150 | -0.010 | -6.3% | $0.155 | $0.155 | $0.150 | 34,955 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 0 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 2,000 | |
| $0.160 | -0.005 | -3.0% | $0.160 | $0.160 | $0.150 | 44,142 | |
| $0.165 | +0.005 | +3.1% | $0.160 | $0.165 | $0.160 | 22,600 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.160 | $0.160 | 13,019 | |
| $0.160 | 0.000 | 0.0% | $0.160 | $0.165 | $0.150 | 75,675 | |
| $0.160 | 0.000 | 0.0% | $0.165 | $0.165 | $0.160 | 68,939 | |
| $0.160 | 0.000 | 0.0% | $0.165 | $0.165 | $0.160 | 24,805 | |
| $0.160 | -0.010 | -5.9% | $0.170 | $0.170 | $0.158 | 144,389 | |
| $0.170 | +0.010 | +6.3% | $0.165 | $0.170 | $0.165 | 16,616 | |
| $0.160 | -0.005 | -3.0% | $0.160 | $0.163 | $0.160 | 132,203 | |
| $0.165 | +0.005 | +3.1% | $0.165 | $0.165 | $0.165 | 30,000 | |
| $0.160 | 0.000 | 0.0% | $0.150 | $0.160 | $0.150 | 141,130 | |
| $0.160 | +0.010 | +6.7% | $0.160 | $0.160 | $0.160 | 3,250 | |
| $0.150 | +0.020 | +15.4% | $0.130 | $0.160 | $0.130 | 479,177 | |
| $0.130 | -0.010 | -7.1% | $0.130 | $0.130 | $0.125 | 58,028 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 175,783 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 0 | |
| $0.140 | +0.010 | +7.7% | $0.140 | $0.140 | $0.140 | 35,659 | |
| $0.130 | 0.000 | 0.0% | $0.130 | $0.130 | $0.130 | 0 | |
| $0.130 | -0.005 | -3.7% | $0.135 | $0.135 | $0.130 | 100,000 | |
| $0.135 | -0.005 | -3.6% | $0.140 | $0.140 | $0.135 | 115,700 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.140 | 68,555 | |
| $0.140 | +0.005 | +3.7% | $0.140 | $0.150 | $0.140 | 110,617 | |
| $0.135 | +0.005 | +3.8% | $0.135 | $0.135 | $0.135 | 3,644 | |
| $0.130 | -0.005 | -3.7% | $0.130 | $0.140 | $0.130 | 140,514 | |
| $0.135 | +0.010 | +8.0% | $0.135 | $0.135 | $0.135 | 1,292 | |
| $0.125 | -0.005 | -3.8% | $0.130 | $0.130 | $0.125 | 490,635 | |
| $0.130 | +0.015 | +13.0% | $0.125 | $0.190 | $0.125 | 1,791,287 | |
| $0.115 | -0.010 | -8.0% | $0.125 | $0.130 | $0.105 | 346,887 | |
| $0.125 | -0.015 | -10.7% | $0.130 | $0.130 | $0.108 | 662,061 | |
| $0.140 | 0.000 | 0.0% | $0.140 | $0.140 | $0.120 | 292,024 | |
| $0.140 | 0.000 | 0.0% | $0.145 | $0.150 | $0.130 | 624,627 | |
| $0.140 | -0.025 | -15.2% | $0.155 | $0.175 | $0.130 | 1,256,340 | |
| $0.165 | 0.000 | 0.0% | $0.165 | $0.165 | $0.165 | 0 | |
| $0.165 | 0.000 | 0.0% | $0.165 | $0.165 | $0.165 | 0 | |
| $0.165 | 0.000 | 0.0% | $0.165 | $0.165 | $0.165 | 0 | |
| $0.165 | 0.000 | 0.0% | $0.185 | $0.185 | $0.165 | 24,551 | |
| $0.165 | 0.000 | 0.0% | $0.170 | $0.170 | $0.165 | 26,104 | |
| $0.165 | -0.015 | -8.3% | $0.188 | $0.190 | $0.165 | 15,697 | |
| $0.180 | 0.000 | 0.0% | $0.200 | $0.200 | $0.180 | 104,603 | |
| $0.180 | 0.000 | 0.0% | $0.185 | $0.185 | $0.170 | 88,649 | |
| $0.180 | +0.005 | +2.9% | $0.175 | $0.180 | $0.145 | 433,128 | |
| $0.175 | -0.005 | -2.8% | $0.175 | $0.185 | $0.170 | 59,114 | |
| $0.180 | -0.005 | -2.7% | $0.190 | $0.190 | $0.175 | 156,291 | |
| $0.185 | +0.005 | +2.8% | $0.180 | $0.200 | $0.175 | 180,422 | |
| $0.180 | 0.000 | 0.0% | $0.185 | $0.195 | $0.180 | 34,354 | |
| $0.180 | -0.010 | -5.3% | $0.205 | $0.205 | $0.180 | 16,564 | |
| $0.190 | 0.000 | 0.0% | $0.185 | $0.200 | $0.180 | 116,662 | |
| $0.190 | -0.005 | -2.6% | $0.200 | $0.200 | $0.180 | 171,345 | |
| $0.195 | -0.015 | -7.1% | $0.200 | $0.200 | $0.185 | 100,011 | |
| $0.210 | +0.010 | +5.0% | $0.225 | $0.225 | $0.210 | 92,576 | |
| $0.200 | 0.000 | 0.0% | $0.225 | $0.225 | $0.200 | 84,964 | |
| $0.200 | -0.010 | -4.8% | $0.210 | $0.210 | $0.200 | 272,170 | |
| $0.210 | 0.000 | 0.0% | $0.210 | $0.210 | $0.210 | 0 | |
| $0.210 | -0.010 | -4.5% | $0.230 | $0.230 | $0.210 | 38,863 | |
| $0.220 | -0.020 | -8.3% | $0.220 | $0.220 | $0.215 | 45,385 | |
| $0.240 | +0.005 | +2.1% | $0.230 | $0.245 | $0.230 | 131,320 | |
| $0.235 | +0.025 | +11.9% | $0.235 | $0.235 | $0.235 | 15,000 | |
| $0.210 | -0.010 | -4.5% | $0.215 | $0.215 | $0.210 | 223,786 | |
| $0.220 | -0.020 | -8.3% | $0.220 | $0.220 | $0.220 | 72,706 |
- Ticker
- ASX:NXN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 20, 2026
Proposed issue of securities - NXN
Latest deck · Dec 8, 2025
Investor Presentation (December 2025)
Investor deck · 15 slides
Latest news
Nexsen Appointments to Advisory Board
Nov 15, 2026
Closed $0.15 (-3.2%) on Nov 16, 2026
A$1.2 million R&D Tax Incentive refund received
Nov 12, 2026
Closed $0.155 (+3.3%) on Nov 13, 2026
Results of Meeting
Nov 9, 2026
Closed $0.16 (0.0%) on Nov 10, 2026
Nexsen advances kidney diagnostics program
Nov 5, 2026
Closed $0.165 (+3.1%) on Nov 6, 2026
Co Secretary Appoint/Resign and Change of Registered Address
Nov 2, 2026
Closed $0.16 (0.0%) on Nov 3, 2026
ISO 13485 Certification brings StrepSure closer to market
Nov 1, 2026
Closed $0.16 (0.0%) on Nov 2, 2026
Quarterly Report - Q1 FY27
Oct 27, 2026
Closed $0.16 (-3.0%) on Oct 28, 2026
Notice of AGM and Meeting Materials
Oct 7, 2026
Closed $0.135 (+3.8%) on Oct 8, 2026
Professor Shekhar Kumta appointed Executive Director
Sep 30, 2026
Closed $0.115 (-8.0%) on Oct 1, 2026
Nexsen Limited on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 35 in the last 12 months · 37 in all · newest Nov 20, 2026 · oldest 2025
- Decks
- 1 deck · latest Dec 8, 2025
Valuation
Price/book 4.8× against a median of 1.4×: the highest of 10 Diagnostics & research services companies shown. Statements: Year to Jun 30, 2026 · price Nov 19, 2026
- Enterprise value
- $22.78M AUD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 4.8×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Nexsen Limited · ASX:NXN | US$18.05M | US$15.08M | n/a | n/a | n/a | 4.8× | n/a | 0.0× | n/a |
| TFBS Bioscience, Inc. · TPEX:6939 | US$19.81M | US$7.83M | n/a | 1.3× | n/a | 0.6× | −38.6% | 0.0× | n/a |
| SANIGEN Co., Ltd. · KRX:188260 | US$19.66M | US$10.06M | n/a | 2.2× | n/a | 2.3× | −82.6% | 0.1× | n/a |
| NanoRepro AG · XETR:NN6 | US$19.45M | US$11.45M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | n/a |
| Urteste S.A. · GPW:URT | US$19.24M | US$19.10M | n/a | 3,525× | n/a | 3.5× | n/a | 0.0× | n/a |
| Genematrix Inc. · KRX:109820 | US$19.06M | US$6.80M | n/a | 0.8× | 31.7× | 1.4× | −1.7% | 0.0× | n/a |
| Oxford BioDynamics PLC · LSE:OBD | US$18.46M | US$20.77M | n/a | 14.5× | n/a | 4.3× | n/a | 1.3× | n/a |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALB | US$18.41M | US$16.94M | 1.1× | 3.6× | 61.6× | 0.3× | 367.8% | 0.0× | n/a |
| Genedrive PLC · LSE:GDR | US$17.85M | US$18.00M | n/a | 18.0× | n/a | n/a | −684.7% | n/a | n/a |
| Microba Life Sciences Limited · ASX:MAP | US$17.70M | US$15.16M | n/a | 1.6× | n/a | 1.1× | −140.4% | 0.2× | n/a |
| PlexBio Co., Ltd. · TPEX:6572 | US$15.79M | US$7.19M | n/a | 1.9× | n/a | 1.8× | −49.1% | 0.0× | n/a |
| Median of the others | US$18.76M | US$13.30M | 1.1× | 2.2× | 46.7× | 1.4× | −49.1% | 0.0× |
Team and board
Officers
| Officer | Role |
|---|---|
| Amanda Burgess | Company Secretary |
| Sonny Didugu | Company Secretary |
| Mark Muzzin | Founder & Managing Director |
| Shekhar Kumta | Executive Director |
Board
| Director | Role |
|---|---|
| Reece O'Connell | Non-Executive Chairman |
| Grant Pestell | Non-Executive Director |
| Martina Mariano | Non-Executive Director |
| Shekhar Kumta | Executive Director |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2025) | Investor deck | 15 slides | Dec 8, 2025 |
Financials
Annual, in AUD
Income statement
| Line | FY2026 |
|---|---|
| Selling, general and administrative | 2.87M |
| Operating income | -6.86M |
| Depreciation and amortization | 1.46K |
| EBITDA | -6.86M |
| Interest expense | 780.0K |
| Income before tax | -6.55M |
| Net income | -6.55M |
| Earnings per share, basic | -0.03 |
Balance sheet
| Line | FY2026 |
|---|---|
| Cash and equivalents | 4.49M |
| Current assets | 4.99M |
| Total assets | 6.70M |
| Accounts payable | 834.4K |
| Current liabilities | 1.03M |
| Total liabilities | 1.04M |
| Shareholders' equity | 5.66M |
| Shares outstanding | 200.2M |
Cash flow
| Line | FY2026 |
|---|---|
| Capital spending | 0 |
| Cash from financing | 7.41M |
| Change in cash | 4.07M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Proposed issue of securities - NXN | Nov 20, 2026 | Financing | ASX |
| Nexsen Appointments to Advisory Board | Nov 15, 2026 | Other filings | ASX |
| A$1.2 million R&D Tax Incentive refund received | Nov 12, 2026 | Results | ASX |
| Results of Meeting | Nov 9, 2026 | Meeting outcome | ASX |
| Nexsen advances kidney diagnostics program | Nov 5, 2026 | Other filings | ASX |
| Co Secretary Appoint/Resign and Change of Registered Address | Nov 2, 2026 | Other filings | ASX |
| ISO 13485 Certification brings StrepSure closer to market | Nov 1, 2026 | Operations update | ASX |
| Quarterly Report - Q1 FY27 | Oct 27, 2026 | Quarterly report | ASX |
| Quarterly Report - Q1 FY27 | Oct 27, 2026 | Quarterly report | ASX |
| Notice of AGM and Meeting Materials | Oct 7, 2026 | Meeting notice | ASX |
All 37 filings
Cap table
Built by 6ix from Nexsen Limited’s releases
- Common shares
- 201,996,200
- Fully diluted
- 201,996,200
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 201,996,200 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 201,996,200 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Amanda Burgess | Company Secretary · Since at least Nov 2, 2026 |
| Grant Pestell | Non-Executive Director · Since at least Nov 17, 2026 |
| Mark Muzzin | Founder & Managing Director · Since at least Nov 17, 2026 |
| Martina Mariano | Non-Executive Director · Since at least Nov 17, 2026 |
| Reece O'Connell | Non-Executive Chairman · Since at least Nov 17, 2026 |
| Sanje Mahasivam | CTO & Research Team Leader · Nov 4, 2026 – Nov 4, 2026 · Past |
| Shekhar Kumta | Executive Director · Since at least Sep 30, 2026 |
| Sonny Didugu | Company Secretary · Since at least Nov 17, 2026 |
Log in to ask 6ix AI your own questions about Nexsen Limited.